Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,126 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05841563 | Clinical Trial of PM54 in Advanced Solid Tumors Patients. | recruiting | Phase 1 | 125 | PharmaMarINDUSTRY | 3 | Sep 24, 2025 | clinicaltrials |
| NCT05216432 | First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer | recruiting | Phase 1 | 930 | Relay Therapeutics, Inc.INDUSTRY | 5 | Sep 22, 2025 |
| clinicaltrials |
| NCT06709469 | Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults(REALL_CART) | recruiting | Phase 1 | 10 | Instituto de Investigación Hospital Universitario La PazOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT05974774 | Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors | recruiting | Phase 3 | 1,600 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 19, 2025 | clinicaltrials |
| NCT05223413 | REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs(RESILIENCE) | recruiting | N/A | 608 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIOTHER | 6 | Sep 18, 2025 | clinicaltrials |
| NCT04064359 | Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors | recruiting | Phase 1 | 200 | Oxford BioTherapeutics LtdINDUSTRY | 5 | Sep 16, 2025 | clinicaltrials |
| NCT05658640 | HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies(HEM-iSMART D) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 15 | Sep 16, 2025 | clinicaltrials |
| NCT05745714 | HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART C) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT05751044 | HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART B) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT07034976 | Efficacy of Non-ablative Radiofrequency Combined With Pelvic Floor Muscle Training for Genitourinary Syndrome of Menopause in Breast Cancer Survivors (RF-SGM) | recruiting | N/A | 50 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT05911750 | Prevalence and Clinical Implications of HPV Infection in Male IBD Patients(PAPIMALE) | recruiting | — | 384 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06732193 | Fissios© and Postoperative Complications (FPoC Trial)(FPoC) | recruiting | N/A | 560 | Carlos Alfredo Fraile Olivero, MD, PhD.OTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT07168096 | Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making. | recruiting | — | 540 | Fundación Sociedad Española de Oncologia MédicaOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT07064330 | Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.(NGF-GRACE) | recruiting | — | 30 | Instituto de Investigación Biomédica de SalamancaOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT05372354 | A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma | recruiting | Phase 1 / Phase 2 | 260 | Bristol-Myers SquibbINDUSTRY | 5 | Sep 5, 2025 | clinicaltrials |
| NCT04098146 | Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis | recruiting | — | 300 | AO Innovation Translation CenterOTHER | 8 | Sep 4, 2025 | clinicaltrials |
| NCT05874401 | Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan | recruiting | Phase 4 | 302 | Pharmacosmos A/SINDUSTRY | 1 | Sep 4, 2025 | clinicaltrials |
| NCT06852014 | Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study | recruiting | N/A | 20 | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT06490536 | The Sagittarius Trial | recruiting | Phase 3 | 700 | IFOM ETS - The AIRC Institute of Molecular OncologyOTHER | 3 | Aug 29, 2025 | clinicaltrials |
| NCT07148154 | Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations | recruiting | — | 3,000 | MiMARK Diagnostics, S.L.INDUSTRY | 1 | Aug 29, 2025 | clinicaltrials |
| NCT03850574 | Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia(TUSCANY) | recruiting | Phase 1 / Phase 2 | 240 | Aptose Biosciences Inc.INDUSTRY | 6 | Aug 26, 2025 | clinicaltrials |
| NCT04120935 | ALFAOMEGA Master Observational Trial(ALFAOMEGA) | recruiting | — | 3,000 | IFOM ETS - The AIRC Institute of Molecular OncologyOTHER | 2 | Aug 24, 2025 | clinicaltrials |
| NCT05101382 | A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)(ALFAOMEGA-R) | recruiting | — | 500 | IFOM ETS - The AIRC Institute of Molecular OncologyOTHER | 2 | Aug 24, 2025 | clinicaltrials |
| NCT05607420 | Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma(NatHaLi-01) | recruiting | Phase 1 / Phase 2 | 80 | Cellectis S.A.INDUSTRY | 3 | Aug 24, 2025 | clinicaltrials |
| NCT05835609 | PM534 Administered Intravenously to Patients With Advanced Solid Tumors | recruiting | Phase 1 | 30 | PharmaMarINDUSTRY | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07075016 | Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy(EVOLVE 1) | recruiting | Phase 3 | 227 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 16 | Aug 19, 2025 | clinicaltrials |
| NCT06868355 | APACE - Feasibility of Using Accelerometers to Measure Physical Activity in Cancer Patients on Early Phase Clinical Trials(APACE) | recruiting | — | 40 | University of ManchesterOTHER | 3 | Aug 14, 2025 | clinicaltrials |
| NCT07120867 | Impact of Pleural Manometry on the Assessment and Treatment of Malignant Pleural Effusion: A Pilot Clinical Trial | recruiting | N/A | 95 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT07018960 | "Multicenter Registry for Chest Wall Reconstruction Using Custom Dynamic Prostheses (PRODIPET)"(PRODIPET) | recruiting | N/A | 60 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07111195 | Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)(SINUE) | recruiting | — | 140 | Juan M Garcia-GomezOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT05885009 | Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)(HOPE-PROSTATE) | recruiting | — | 240 | SOLTI Breast Cancer Research GroupOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT06002022 | Evaluation of Improvements in Patient-reported Quality of Life(REBECCA-QoL) | recruiting | N/A | 110 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07100288 | Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer(INFPELV) | recruiting | — | 200 | Complejo Hospitalario Universitario Insular Materno InfantilOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT06154785 | Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)(CROSS) | recruiting | — | 300 | Bordeaux Colorectal Institute AcademyOTHER | 8 | Aug 1, 2025 | clinicaltrials |
| NCT07045909 | Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)(GEM-AnitoFIRST) | recruiting | Phase 2 | 30 | PETHEMA FoundationOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07096258 | EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients(EMPATHY NSCLC) | recruiting | — | 1,000 | Hedera Dx SAINDUSTRY | 4 | Jul 31, 2025 | clinicaltrials |
| NCT07058207 | Weight Management in Obese Cancer Patients During Curative Active Treatment(CANOBESE) | recruiting | N/A | 50 | Institut d'Investigació Biomèdica de BellvitgeOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT04832607 | Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections(TRACE) | recruiting | Phase 3 | 149 | Tobias FeuchtingerOTHER | 6 | Jul 18, 2025 | clinicaltrials |
| NCT04704323 | CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia | recruiting | Phase 1 | 18 | Catapult TherapeuticsINDUSTRY | 2 | Jul 17, 2025 | clinicaltrials |
| NCT07067710 | The Use of Combined Motor Imagery and Action Observation to Evaluate the Influence on Functional Parameters Such as Strength, Range of Motion, Pain or Fear of Movement Among Others, in Females Breast Cancer Survivors.(IM-OA23) | recruiting | N/A | 108 | Fundacion Miguel ServetOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07057232 | Chronic Insomnia in Non-Cancer Pain Patients(PainSomnia) | recruiting | — | 385 | Germans Trias i Pujol HospitalOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT06409936 | PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML(PEARL) | recruiting | Phase 2 | 160 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT04958720 | Spanish Registry of Esophagogastric Cancer(AGAMENON) | recruiting | — | 10,000 | Fundación Sociedad Española de Oncologia MédicaOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06669117 | FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations | recruiting | Phase 1 / Phase 2 | 140 | Pierre Fabre MedicamentINDUSTRY | 9 | Jul 2, 2025 | clinicaltrials |
| NCT04740424 | FS222 First in Human Study in Patients With Advanced Malignancies | recruiting | Phase 1 | 260 | invoX Pharma LimitedINDUSTRY | 7 | Jul 1, 2025 | clinicaltrials |
| NCT06163391 | A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer | recruiting | Phase 1 | 40 | SOTIO Biotech AGINDUSTRY | 5 | Jun 29, 2025 | clinicaltrials |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors(SPARTA) | recruiting | Phase 2 | 497 | Apollomics Inc.INDUSTRY | 11 | Jun 27, 2025 | clinicaltrials |
| NCT07039994 | Early Palliative Care in Patients With Advanced Lung Cancer Using an e-Health Ecosystem(AIRPAL) | recruiting | N/A | 200 | Jesús GonzálezOTHER_GOV | 1 | Jun 26, 2025 | clinicaltrials |
| NCT05692999 | Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study(Pulse) | recruiting | Phase 3 | 1,166 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 3 | Jun 25, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials